4P Therapeutics
4P Therapeutics is a clinical subsidiary of Nutriband Inc. focused on research and development of novel drug delivery technologies and therapeutics, especially in transdermal products for currently injected compounds. They develop products from pre-clinical testing to clinical manufacturing and early stage clinical development, aiming to improve safety, efficacy, and therapeutic outcomes for patients, physicians, and payers.
Industries
Nr. of Employees
small (1-50)
4P Therapeutics
approximately 40 minutes from Atlanta Hartsfield-Jackson International Airport (ATL) near Peachtree Corners off GA-141
Products
Transdermal drug delivery systems (patches)
Patch-based drug delivery systems designed to enable non-invasive delivery of compounds that are often administered by injection, including small molecules, peptides, proteins and macromolecules.
Transdermal drug delivery systems (patches)
Patch-based drug delivery systems designed to enable non-invasive delivery of compounds that are often administered by injection, including small molecules, peptides, proteins and macromolecules.
Services
End-to-end preclinical evaluation including physicochemical assessment, delivery technology selection, formulation/device configuration, analytical method development, and in vitro/in vivo testing.
Development of small-scale manufacturing processes, qualification of test methods, specification setting, stability studies and lot release testing to support IND filings and clinical manufacturing.
Protocol design and execution, IRB submissions, TMF maintenance, clinical monitoring, data management, medical writing, biostatistics and PK analysis for early-stage through pivotal trials.
Small-scale manufacturing for transdermal patches, drug solutions and devices (film casting, die cutting, lamination, assembly, pouching) and contract manufacturing services for topical/transdermal products.
Electromechanical design, materials science, human factors/product design, and risk analysis to integrate device functionality with drug formulations.
Regulatory strategy development, IND preparation, interactions with regulatory authorities, amendments and annual report filings.
End-to-end preclinical evaluation including physicochemical assessment, delivery technology selection, formulation/device configuration, analytical method development, and in vitro/in vivo testing.
Development of small-scale manufacturing processes, qualification of test methods, specification setting, stability studies and lot release testing to support IND filings and clinical manufacturing.
Protocol design and execution, IRB submissions, TMF maintenance, clinical monitoring, data management, medical writing, biostatistics and PK analysis for early-stage through pivotal trials.
Small-scale manufacturing for transdermal patches, drug solutions and devices (film casting, die cutting, lamination, assembly, pouching) and contract manufacturing services for topical/transdermal products.
Electromechanical design, materials science, human factors/product design, and risk analysis to integrate device functionality with drug formulations.
Regulatory strategy development, IND preparation, interactions with regulatory authorities, amendments and annual report filings.
Expertise Areas
- Transdermal drug delivery
- Drug-device combination development
- Preclinical feasibility and in vitro/in vivo testing
- CMC development and small-scale clinical manufacturing
Key Technologies
- Transdermal patch technologies
- Film casting and lamination
- Die cutting and pouching
- Electromechanical device design